Cargando…

The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib

BACKGROUND: The efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy can be measured based on the rate of treatment response, based on the Response Evaluation Criteria in Solid Tumors (RECIST) criteria or progression-free survival (PFS). However, there are some p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Dong Il, Kim, Sun Young, Kim, Ju Ock, Jung, Sung Soo, Park, Hee Sun, Moon, Jae Young, Chung, Chae Uk, Kim, Song Soo, Seo, Jae Hee, Lee, Jeong Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620323/ https://www.ncbi.nlm.nih.gov/pubmed/26508917 http://dx.doi.org/10.4046/trd.2015.78.4.315

Ejemplares similares

Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014)

Stevens–Johnson Syndrome and Hypothermia Associated with Anti-tuberculosis Medication in a Patient with Heart Failure
por: Jung, Sang-Ok, et al.
Publicado: (2015)

Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs
por: Park, Yeon Hee, et al.
Publicado: (2016)

CT-Guided Percutaneous Transthoracic Needle Biopsy Using the Additional Laser Guidance System by a Pulmonologist with 2 Years of Experience in CT-Guided Percutaneous Transthoracic Needle Biopsy
por: Jeon, Min-Cheol, et al.
Publicado: (2018)

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy
por: Park, Yeon-Hee, et al.
Publicado: (2015)

Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer
por: Jung, Sang Ok, et al.
Publicado: (2015)

Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis
por: Jung, Sung-Soo, et al.
Publicado: (2015)

Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors
por: Yu, Mi Hye, et al.
Publicado: (2019)

Spontaneous regression of non-small cell lung cancer that progressed after multiple chemotherapies: A case report
por: Chung, Chaeuk, et al.
Publicado: (2015)

Alitretinoin Treatment for Gefitinib-Induced Paronychia
por: Lee, Soo Young, et al.
Publicado: (2019)

Antibacterial effect of cell-free supernatant fraction from Lactobacillus paracasei CH88 against Gardnerella vaginalis
por: Moon, Eun Chae, et al.
Publicado: (2022)

Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
por: Yoo, Su Jin, et al.
Publicado: (2012)

Screening of Brain Metastasis with Limited Magnetic Resonance Imaging (MRI): Clinical Implications of Using Limited Brain MRI During Initial Staging for Non-small Cell Lung Cancer Patients
por: Kim, Sun-Young, et al.
Publicado: (2005)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
por: Yu, Jongwook, et al.
Publicado: (2021)

Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia
por: Yeo, Min-Kyung, et al.
Publicado: (2018)

Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults
por: Moon, Joon Ho, et al.
Publicado: (2016)

Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel
por: Park, Ji Young, et al.
Publicado: (2017)

Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD‐1/PD‐L1 inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2018)

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer
por: Kim, Young Saing, et al.
Publicado: (2016)

Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
por: Park, Soo-Yeon, et al.
Publicado: (2010)

A Case of Granular Cell Tumor of the Trachea
por: Joung, Mi-Kyong, et al.
Publicado: (2007)

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2021)

Prognostic value of quality of life score in disease-free survivors of surgically-treated lung cancer
por: Yun, Young Ho, et al.
Publicado: (2016)

Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib
por: Park, Sejeong, et al.
Publicado: (2018)

Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma
por: Choi, Hayoung, et al.
Publicado: (2015)

Efficacy and Tolerability of Split-Dose PEG Compared with Split-Dose Aqueous Sodium Phosphate for Outpatient Colonoscopy: A Randomized, Controlled Trial
por: Seo, Eun Hee, et al.
Publicado: (2011)

Ethics in the Intensive Care Unit
por: Moon, Jae Young, et al.
Publicado: (2015)

Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation
por: Jang, Sunhyae, et al.
Publicado: (2012)

Remarkable Effect of Gefitinib Retreatment in a Lung Cancer Patient With Lepidic Predominat Adenocarcinoma who had Experienced Favorable Results From Initial Treatment With Gefitinib: A Case Report
por: Lee, Su Jin, et al.
Publicado: (2012)

Genome-wide comparative analysis of the Brassica rapa gene space reveals genome shrinkage and differential loss of duplicated genes after whole genome triplication
por: Mun, Jeong-Hwan, et al.
Publicado: (2009)

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells
por: Cho, Jae Hee, et al.
Publicado: (2017)

Outcomes of Total Hip Arthroplasty in Patients with Osteonecrosis of the Femoral Head Following Surgical Treatment of Brain Tumors
por: Lim, Seung-Jae, et al.
Publicado: (2019)

Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab
por: Ha, Joo Young, et al.
Publicado: (2021)

RoBANS 2: A Revised Risk of Bias Assessment Tool for Nonrandomized Studies of Interventions
por: Seo, Hyun-Ju, et al.
Publicado: (2023)

Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer
por: Lee, Sung Uk, et al.
Publicado: (2022)

Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status
por: Sun, Young JUNG, et al.
Publicado: (2011)

Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
por: Seo, Yoojeong, et al.
Publicado: (2020)

Prognostic value of metabolic parameters measured by pretreatment dual-time-point (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with intrahepatic or perihilar cholangiocarcinoma: A STROBE study
por: Hwang, Jae Pil, et al.
Publicado: (2021)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
por: Park, Yong Eun, et al.
Publicado: (2021)

Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration
por: Lee, Bongjin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iu5ecaeb6s2b4fe4qk4c4gbtio